NYSE - Delayed Quote
USD
Bristol-Myers Squibb Company (BMY)
60.57
-0.98
(-1.59%)
At close: October 28 at 4:00:02 PM EDT
61.47
+0.90
(+1.49%)
Pre-Market: 4:00:00 AM EDT
Trade BMY on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreAnalyst Insights
Top Analyst
Goldman Sachs
61/100
Analyst Price Targets
Analyst Recommendations
-
Strong Buy
-
Buy
-
Hold
-
Underperform
-
Sell
Latest Rating
Date
10/26/2026
Analyst
Piper Sandler
Rating Action
Maintains
Rating
Overweight
Price Action
Lowers
Price Target
82 -> 78
Top Analysts
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more| Analyst
|
Overall Score
|
Direction Score
|
Price Score
|
Latest Rating
|
Price Target
|
Date
|
|---|---|---|---|---|---|---|
|
Goldman Sachs
|
61 | 54 | 100 | Neutral
|
57 | 2025-12-02 |
|
Piper Sandler
|
61 | 65 | 100 | Overweight
|
78 | 2026-10-27 |
|
JP Morgan
|
50 | 54 | 84 | Overweight
|
73 | 2026-07-31 |
|
B of A Securities
|
47 | 34 | 100 | Buy
|
66 | 2026-07-10 |
|
Morgan Stanley
|
46 | 43 | 91 | Underweight
|
41 | 2026-10-07 |
|
Guggenheim
|
39 | 41 | 61 | Buy
|
75 | 2026-08-01 |
|
Citigroup
|
34 | 13 | 100 | Neutral
|
70 | 2026-08-03 |
|
UBS
|
34 | 16 | 91 | Buy
|
65 | 2026-01-07 |
|
Truist Securities
|
34 | 16 | 99 | Buy
|
70 | 2026-08-01 |
|
Barclays
|
33 | 14 | 92 | Overweight
|
75 | 2026-02-21 |
Rows per page
1-10 of 13
Upgrades & Downgrades
| Maintains | Piper Sandler: Overweight to Overweight | 10/26/2026 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 10/13/2026 |
| Maintains | Cantor Fitzgerald: Neutral to Neutral | 10/8/2026 |
| Maintains | Morgan Stanley: Underweight to Underweight | 10/7/2026 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 10/5/2026 |
| Reiterates | Piper Sandler: Overweight to Overweight | 9/16/2026 |
